BFA
ALBO

BlackRock Fund Advisors’s Albireo Pharma Inc ALBO Stock Holding History

BlackRock Fund Advisors’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$0 Sell
17
-4,209
-100% -$87.3K ﹤0.01% 4259
2016
Q3 		$55K Buy
4,226
+3,853
+1,033% +$45.4K ﹤0.01% 3753
2016
Q2 		$3K Sell
373
-3,829
-91% -$42.2K ﹤0.01% 4189
2016
Q1 		$42K Sell
4,202
-311
-7% -$2.77K ﹤0.01% 3839
2015
Q4 		$46K Buy
4,513
+1,849
+69% +$19.1K ﹤0.01% 3897
2015
Q3 		$35K Sell
2,664
-71
-3% -$1.79K ﹤0.01% 3866
2015
Q2 		$85K Buy
2,735
+330
+14% +$11.1K ﹤0.01% 3759
2015
Q1 		$86K Buy
2,405
+640
+36% +$27K ﹤0.01% 3645
2014
Q4 		$70K Buy
1,765
+126
+8% +$5.53K ﹤0.01% 3648
2014
Q3 		$82K Sell
1,639
-119
-7% -$6.84K ﹤0.01% 3661
2014
Q2 		$114K Buy
1,758
+50
+3% +$3.48K ﹤0.01% 3602
2014
Q1 		$140K Buy
1,708
+207
+14% +$18.8K ﹤0.01% 3542
2013
Q4 		$103K Buy
1,501
+62
+4% +$4.54K ﹤0.01% 3570
2013
Q3 		$136K Buy
1,439
+113
+9% +$14.7K ﹤0.01% 3497
2013
Q2 		$166K Buy
+1,326
New +$138K ﹤0.01% 3386

Other funds holding ALBO

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return

BlackRock Fund Advisors's ALBO Position: Q4 2016 in Review

BlackRock Fund Advisors reduced its Albireo Pharma Inc (ALBO) stake by 100% in Q4 2016, selling an estimated $87.3K and leaving 17 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4259.

BlackRock Fund Advisors first reported a position in ALBO in Q2 2013 and has held it in 15 quarters since. The position peaked at $166K in Q2 2013. 19 funds tracked by Wall St. Rank hold ALBO as of Q4 2016.

  • BlackRock Fund Advisors held 17 shares of Albireo Pharma Inc worth $0 as of Q4 2016.
  • BlackRock Fund Advisors sold 4,209 Albireo Pharma Inc shares in Q4 2016, an estimated $87.3K.
  • Albireo Pharma Inc made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #4259 holding.
  • BlackRock Fund Advisors first reported a position in Albireo Pharma Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Albireo Pharma Inc position peaked at $166K in Q2 2013.
  • 19 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.